Atlas Trials

A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants

Clinical trial NCT07219030 · RECRUITING

Trial details

NCT number
NCT07219030
Sponsor
AbbVie
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteer
Start date
2025-10-08
Primary completion
2027-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.